Human Immunodeficiency Virus (HIV) Subject – Science and Tech Context – Moderna, the Massachusetts­ based American biotechnology company, has indicated that it may begin human trials for a vaccine for HIV (human immuno deficiency virus) in September, according to theClinicalTrials.gov website, employing the same m­RNA platform that it has used in its COVID­19 […]